Bibliography
- Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. Antivir Res 2009;81:6-15
- World Health Organisation. Immunisation, Vaccines and Biologicals. Initiative for Vaccine Research (IVR): tick-borne disease. Last Update 25 January 20008. Internet. Available from: http://www.who.int/immunization/topics/tick_encephalitis/en/index.html. [Last accessed on 29 May 2009]
- Randolph SE. Tick-borne encephalitis virus, ticks and humans: short-term and long-term dynamics. Curr Opin Infect Dis 2008;21:462-7
- Gunther G, Haglund M. Tick-borne encephalopathies: epidemiology, diagnosis, treatment and prevention. CNS Drugs 2005;19:1009-32
- Kaiser R. Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 2002;291 (Suppl 33):58-61
- Haglund M, Forsgren M, Lindh G, Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 1996;28:217-24
- Kunze U, Baumhackl U, Bretschneider R, et al. The golden agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis. Wien Med Wochenschr 2005;155:289-94
- Ehrlich HJ, Pavlova BG, Fritsch S, et al. Randomized, Phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity. Vaccine 2003;22:217-23
- Loew-Baselli A, Konior R, Pavlova BG, et al. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine 2006;24:5256-63
- Harabacz I, Bock H, Jungst C, et al. A randomized Phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 1992;10:145-50
- Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis – correlation with clinical outcome. Infection 2000;28:78-84
- Holzmann H, Kundi M, Stiasny K, et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 1996;48:102-7
- Schondorf I, Beran J, Cizkova D, et al. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 2007;25:1470-5
- Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol 2005;17:457-62
- Renshaw M, Rockwell J, Engleman C, et al. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002;169:4697-701
- Grewe M. Chronological ageing and photoageing of dendritic cells. Clin Exp Dermatol 2001;26:608-12
- Allman D, Miller JP. B cell development and receptor diversity during aging. Curr Opin Immunol 2005;17:463-7
- Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002;2:659-66
- Hainz U, Aigner K, Berger P. Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccination? Wien Klin Wochenschr (German) 2002;28:167-70
- Hainz U, Jenewein B, Asch E, et al. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005;23:3232-5
- Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007;4:9. Published online 11 December 2007, doi:10.1186/1742-4933-4-9